203 related articles for article (PubMed ID: 37919899)
1. Targeted, safe, and efficient gene delivery to human hematopoietic stem and progenitor cells in vivo using the engineered AVID adenovirus vector platform.
Yao J; Atasheva S; Wagner N; Di Paolo NC; Stewart PL; Shayakhmetov DM
Mol Ther; 2024 Jan; 32(1):103-123. PubMed ID: 37919899
[TBL] [Abstract][Full Text] [Related]
2. Enrichment of human hematopoietic stem/progenitor cells facilitates transduction for stem cell gene therapy.
Baldwin K; Urbinati F; Romero Z; Campo-Fernandez B; Kaufman ML; Cooper AR; Masiuk K; Hollis RP; Kohn DB
Stem Cells; 2015 May; 33(5):1532-42. PubMed ID: 25588820
[TBL] [Abstract][Full Text] [Related]
3. Preferential Expansion of Human CD34
Christopher AC; Venkatesan V; Karuppusamy KV; Srinivasan S; Babu P; Azhagiri MKK; Chambayil K; Bagchi A; Rajendiran V; Ravi NS; Kumar S; Marepally SK; Mohankumar KM; Srivastava A; Velayudhan SR; Thangavel S
Hum Gene Ther; 2022 Feb; 33(3-4):188-201. PubMed ID: 34486377
[TBL] [Abstract][Full Text] [Related]
4. In vivo gene delivery into hCD34+ cells in a humanized mouse model.
Frecha C; Fusil F; Cosset FL; Verhoeyen E
Methods Mol Biol; 2011; 737():367-90. PubMed ID: 21590405
[TBL] [Abstract][Full Text] [Related]
5. The CCR5 Gene Edited CD34
Karuppusamy KV; Demosthenes JP; Venkatesan V; Christopher AC; Babu P; Azhagiri MK; Jacob A; Ramalingam VV; Rangaraj S; Murugesan MK; Marepally SK; Varghese GM; Srivastava A; Kannangai R; Thangavel S
Front Immunol; 2022; 13():792684. PubMed ID: 35359982
[TBL] [Abstract][Full Text] [Related]
6. Different Human Immune Lineage Compositions Are Generated in Non-Conditioned NBSGW Mice Depending on HSPC Source.
Hess NJ; Lindner PN; Vazquez J; Grindel S; Hudson AW; Stanic AK; Ikeda A; Hematti P; Gumperz JE
Front Immunol; 2020; 11():573406. PubMed ID: 33193358
[TBL] [Abstract][Full Text] [Related]
7. Ex Vivo Expansion of CD34
Bari S; Zhong Q; Fan X; Poon Z; Lim AST; Lim TH; Dighe N; Li S; Chiu GNC; Chai CLL; Hwang WYK
Stem Cells Transl Med; 2018 May; 7(5):376-393. PubMed ID: 29392885
[TBL] [Abstract][Full Text] [Related]
8. Optimization of adenovirus serotype 35 vectors for efficient transduction in human hematopoietic progenitors: comparison of promoter activities.
Sakurai F; Kawabata K; Yamaguchi T; Hayakawa T; Mizuguchi H
Gene Ther; 2005 Oct; 12(19):1424-33. PubMed ID: 15944730
[TBL] [Abstract][Full Text] [Related]
9. Improving Gene Therapy Efficiency through the Enrichment of Human Hematopoietic Stem Cells.
Masiuk KE; Brown D; Laborada J; Hollis RP; Urbinati F; Kohn DB
Mol Ther; 2017 Sep; 25(9):2163-2175. PubMed ID: 28663101
[TBL] [Abstract][Full Text] [Related]
10. In vivo HSC transduction in rhesus macaques with an HDAd5/3+ vector targeting desmoglein 2 and transiently overexpressing cxcr4.
Wang H; Germond A; Li C; Gil S; Kim J; Kiem HP; Lieber A
Blood Adv; 2022 Aug; 6(15):4360-4372. PubMed ID: 35679480
[TBL] [Abstract][Full Text] [Related]
11. Adenovirus vectors in hematopoietic stem cell genome editing.
Li C; Lieber A
FEBS Lett; 2019 Dec; 593(24):3623-3648. PubMed ID: 31705806
[TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of ex vivo expanded CD34
Zhang Y; Shen B; Guan X; Qin M; Ren Z; Ma Y; Dai W; Ding X; Jiang Y
Stem Cell Res Ther; 2019 Jun; 10(1):173. PubMed ID: 31196160
[TBL] [Abstract][Full Text] [Related]
13. CD90-targeted lentiviral vectors for HSC gene therapy.
Berckmueller K; Thomas J; Taha EA; Choo S; Madhu R; Kanestrom G; Rupert PB; Strong R; Kiem HP; Radtke S
Mol Ther; 2023 Oct; 31(10):2901-2913. PubMed ID: 37550965
[TBL] [Abstract][Full Text] [Related]
14. Single-cell assessment of transcriptome alterations induced by Scriptaid in early differentiated human haematopoietic progenitors during ex vivo expansion.
Hua P; Kronsteiner B; van der Garde M; Ashley N; Hernandez D; Tarunina M; Hook L; Choo Y; Roberts I; Mead A; Watt SM
Sci Rep; 2019 Mar; 9(1):5300. PubMed ID: 30923342
[TBL] [Abstract][Full Text] [Related]
15. Efficient Ex Vivo Engineering and Expansion of Highly Purified Human Hematopoietic Stem and Progenitor Cell Populations for Gene Therapy.
Zonari E; Desantis G; Petrillo C; Boccalatte FE; Lidonnici MR; Kajaste-Rudnitski A; Aiuti A; Ferrari G; Naldini L; Gentner B
Stem Cell Reports; 2017 Apr; 8(4):977-990. PubMed ID: 28330619
[TBL] [Abstract][Full Text] [Related]
16. Dual SP/ALDH functionalities refine the human hematopoietic Lin-CD34+CD38- stem/progenitor cell compartment.
Pierre-Louis O; Clay D; Brunet de la Grange P; Blazsek I; Desterke C; Guerton B; Blondeau C; Malfuson JV; Prat M; Bennaceur-Griscelli A; Lataillade JJ; Le Bousse-Kerdilès MC
Stem Cells; 2009 Oct; 27(10):2552-62. PubMed ID: 19650038
[TBL] [Abstract][Full Text] [Related]
17. Tightly regulated gene expression in human hematopoietic stem cells after transduction with helper-dependent Ad5/35 vectors.
Wang H; Cao H; Wohlfahrt M; Kiem HP; Lieber A
Exp Hematol; 2008 Jul; 36(7):823-31. PubMed ID: 18394775
[TBL] [Abstract][Full Text] [Related]
18. Targeted transduction of CD34+ hematopoietic progenitor cells in nonpurified human mobilized peripheral blood mononuclear cells.
Liang M; Pariente N; Morizono K; Chen IS
J Gene Med; 2009 Mar; 11(3):185-96. PubMed ID: 19152374
[TBL] [Abstract][Full Text] [Related]
19.
Chandra S; Cristofori P; Fonck C; O'Neill CA
Toxicol Pathol; 2019 Jul; 47(5):656-660. PubMed ID: 31064282
[TBL] [Abstract][Full Text] [Related]
20. Efficient gene transfer into human cord blood CD34+ cells and the CD34+CD38- subset using highly purified recombinant adeno-associated viral vector preparations that are free of helper virus and wild-type AAV.
Nathwani AC; Hanawa H; Vandergriff J; Kelly P; Vanin EF; Nienhuis AW
Gene Ther; 2000 Feb; 7(3):183-95. PubMed ID: 10694794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
